Hypopharynx
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. (NCT03737968) | Yonsei University | 2019-01-02 |
| Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium (NCT01321892) | Icahn School of Medicine at Mount Sinai | 2009-06-01 |
Track Hypopharynx automatically
Every clearance here is in the API, with alerts when new ones post.